BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE

Translated title of the contribution: The rational principles of the therapy of supraventricular tachycardia and its management

C. Rostagno, G. Bertini, L. Padeletti, A. Michelucci, S. Del Pace, G. F. Gensini

Research output: Contribution to journalArticle

Abstract

Supraventricular arrhythmias are frequently encountered in clinical practice. Despite their common anatomical origin above the division of His' bundle into bundle branches, these arrhythmias have profoundly different electrophysiological mechanisms, clinical significances and responses to treatment. Although 12-lead surface ECG usually enables correct identification, facilitating treatment choice in the emergency room, electrophysiologic testing to determine the site of origin and the pathway of the arrhythmia may be necessary for the management of definitive treatment. Drug therapy is efficient for conversion to sinus treatment in 80-90% of patients with new onset arrhythmias. Class Ic antiarrhythmics (propafenone and flecainide) are particularly useful for atrial fibrillation, while adenosine and verapamil are the drugs of choice for reentry tachycardias. Atrial flutter is a noteworthy exception, and DC shock is often required to terminate the arrhythmia. The results of antiarrhythmic therapy for long term prevention of recurrences are often disappointing. Recent surgical and technological developments, in particular transcatheter ablation procedures, now allow definitive resolution of most reentrant arrhythmias, including preexcitation syndrome. This report discusses current concepts regarding the management of supraventricular arrhythmias.

Original languageItalian
Pages (from-to)235-243
Number of pages9
JournalAnnali Italiani di Medicina Interna
Volume8
Issue number4
Publication statusPublished - 1993

Fingerprint

Supraventricular Tachycardia
Cardiac Arrhythmias
Therapeutics
Pre-Excitation Syndromes
Propafenone
Flecainide
Bundle of His
Atrial Flutter
Verapamil
Tachycardia
Adenosine
Atrial Fibrillation
Hospital Emergency Service
Shock
Electrocardiography
Recurrence
Drug Therapy
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Rostagno, C., Bertini, G., Padeletti, L., Michelucci, A., Del Pace, S., & Gensini, G. F. (1993). BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE. Annali Italiani di Medicina Interna, 8(4), 235-243.

BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE. / Rostagno, C.; Bertini, G.; Padeletti, L.; Michelucci, A.; Del Pace, S.; Gensini, G. F.

In: Annali Italiani di Medicina Interna, Vol. 8, No. 4, 1993, p. 235-243.

Research output: Contribution to journalArticle

Rostagno, C, Bertini, G, Padeletti, L, Michelucci, A, Del Pace, S & Gensini, GF 1993, 'BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE', Annali Italiani di Medicina Interna, vol. 8, no. 4, pp. 235-243.
Rostagno C, Bertini G, Padeletti L, Michelucci A, Del Pace S, Gensini GF. BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE. Annali Italiani di Medicina Interna. 1993;8(4):235-243.
Rostagno, C. ; Bertini, G. ; Padeletti, L. ; Michelucci, A. ; Del Pace, S. ; Gensini, G. F. / BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE. In: Annali Italiani di Medicina Interna. 1993 ; Vol. 8, No. 4. pp. 235-243.
@article{98f457aaa2bc4e968d85b8f2283c443d,
title = "BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE",
abstract = "Supraventricular arrhythmias are frequently encountered in clinical practice. Despite their common anatomical origin above the division of His' bundle into bundle branches, these arrhythmias have profoundly different electrophysiological mechanisms, clinical significances and responses to treatment. Although 12-lead surface ECG usually enables correct identification, facilitating treatment choice in the emergency room, electrophysiologic testing to determine the site of origin and the pathway of the arrhythmia may be necessary for the management of definitive treatment. Drug therapy is efficient for conversion to sinus treatment in 80-90{\%} of patients with new onset arrhythmias. Class Ic antiarrhythmics (propafenone and flecainide) are particularly useful for atrial fibrillation, while adenosine and verapamil are the drugs of choice for reentry tachycardias. Atrial flutter is a noteworthy exception, and DC shock is often required to terminate the arrhythmia. The results of antiarrhythmic therapy for long term prevention of recurrences are often disappointing. Recent surgical and technological developments, in particular transcatheter ablation procedures, now allow definitive resolution of most reentrant arrhythmias, including preexcitation syndrome. This report discusses current concepts regarding the management of supraventricular arrhythmias.",
author = "C. Rostagno and G. Bertini and L. Padeletti and A. Michelucci and {Del Pace}, S. and Gensini, {G. F.}",
year = "1993",
language = "Italian",
volume = "8",
pages = "235--243",
journal = "Annali Italiani di Medicina Interna",
issn = "0393-9340",
publisher = "CEPI s.r.l.",
number = "4",

}

TY - JOUR

T1 - BASI RAZIONALI DELLA TERAPIA DELLE TACHICARDIE SOPRAVENTRICOLARI E SUA CONDUZIONE

AU - Rostagno, C.

AU - Bertini, G.

AU - Padeletti, L.

AU - Michelucci, A.

AU - Del Pace, S.

AU - Gensini, G. F.

PY - 1993

Y1 - 1993

N2 - Supraventricular arrhythmias are frequently encountered in clinical practice. Despite their common anatomical origin above the division of His' bundle into bundle branches, these arrhythmias have profoundly different electrophysiological mechanisms, clinical significances and responses to treatment. Although 12-lead surface ECG usually enables correct identification, facilitating treatment choice in the emergency room, electrophysiologic testing to determine the site of origin and the pathway of the arrhythmia may be necessary for the management of definitive treatment. Drug therapy is efficient for conversion to sinus treatment in 80-90% of patients with new onset arrhythmias. Class Ic antiarrhythmics (propafenone and flecainide) are particularly useful for atrial fibrillation, while adenosine and verapamil are the drugs of choice for reentry tachycardias. Atrial flutter is a noteworthy exception, and DC shock is often required to terminate the arrhythmia. The results of antiarrhythmic therapy for long term prevention of recurrences are often disappointing. Recent surgical and technological developments, in particular transcatheter ablation procedures, now allow definitive resolution of most reentrant arrhythmias, including preexcitation syndrome. This report discusses current concepts regarding the management of supraventricular arrhythmias.

AB - Supraventricular arrhythmias are frequently encountered in clinical practice. Despite their common anatomical origin above the division of His' bundle into bundle branches, these arrhythmias have profoundly different electrophysiological mechanisms, clinical significances and responses to treatment. Although 12-lead surface ECG usually enables correct identification, facilitating treatment choice in the emergency room, electrophysiologic testing to determine the site of origin and the pathway of the arrhythmia may be necessary for the management of definitive treatment. Drug therapy is efficient for conversion to sinus treatment in 80-90% of patients with new onset arrhythmias. Class Ic antiarrhythmics (propafenone and flecainide) are particularly useful for atrial fibrillation, while adenosine and verapamil are the drugs of choice for reentry tachycardias. Atrial flutter is a noteworthy exception, and DC shock is often required to terminate the arrhythmia. The results of antiarrhythmic therapy for long term prevention of recurrences are often disappointing. Recent surgical and technological developments, in particular transcatheter ablation procedures, now allow definitive resolution of most reentrant arrhythmias, including preexcitation syndrome. This report discusses current concepts regarding the management of supraventricular arrhythmias.

UR - http://www.scopus.com/inward/record.url?scp=0027756737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027756737&partnerID=8YFLogxK

M3 - Articolo

C2 - 8161480

AN - SCOPUS:0027756737

VL - 8

SP - 235

EP - 243

JO - Annali Italiani di Medicina Interna

JF - Annali Italiani di Medicina Interna

SN - 0393-9340

IS - 4

ER -